Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
1362 14 |
Ultima descărcare din IBN: 2022-04-11 21:21 |
SM ISO690:2012 GÎRBU, Ionel, GREJDIERU, Alexandra, GRIB, Liviu, REVENCO, Valeriu, GÎRBU, Lucia, GUŢU-BAHOV, Cornelia, BAHNEANU, Aura. Tratamentul cu levosimendan în infarctul miocardic acut, provocat de şoc hemoragic. Caz clinic
. In: Analele Ştiinţifice ale USMF „N. Testemiţanu”, 2012, nr. 3(13), pp. 69-73. ISSN 1857-1719. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Analele Ştiinţifice ale USMF „N. Testemiţanu” | ||||||
Numărul 3(13) / 2012 / ISSN 1857-1719 | ||||||
|
||||||
Pag. 69-73 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Treatment with levosimendan in acute myocardial
infarction caused by hemorrhagic shock
Acute myocardial infarction (AMI) is the death of cardiac myocytes caused by prolonged myocardial ischemia. The extension of the ischemic necrosis correlates with the degree of pump failure and mortality, both early (within 10 days of stroke) and late. AMI causes in most cases (90%) have an atherosclerotic substrate and only in 10 % the disease can occur on non atherosclerotic background. An incidence of the AMI development is from massive bleeding, causing severe hypovolemia and prolonged myocardial ischemia. The treatment of the patients,
in addition with complex therapy with conventional cardiotonics, necessarily requires the administration of contemporary positive inotropic preparations – Levosimendan (Simdax). |
||||||
|